Biochemist Takes Charge of Beleaguered NIH Misconduct Office

NIH should take an active role in this process, , but I don’t think we should tell instituions what to do." The 46-year-old biochemist took up the challenge, on October 10. On that day she became the second NIH employee—and the first scientist direct NIH’s efforst on misconduct. The office she leads was created six years ago as part of effort to codify research practices by those who receive federal funds. But its work relating misconduct, which includes investigating allegati


Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

NIH should take an active role in this process, , but I don’t think we should tell instituions what to do." The 46-year-old biochemist took up the challenge, on October 10. On that day she became the second NIH employee—and the first scientist direct NIH’s efforst on misconduct. The office she leads was created six years ago as part of effort to codify research practices by those who receive federal funds. But its work relating misconduct, which includes investigating allegations as well as developing prevention startegies, soon became a full-time job. And the pressures built as NIH’s handling of the subject become a matter of growing concern on Capitol Hill.

Newburgh is an eight-year veteran of NIH, having previously served as deputy director for pharmacological sciences at the general medical sciences institute. She was picked for the job because of her scientific background and her knowledge of NIH procedures, explains ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo